Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.
Abstract:
A melt-kneading method for filling material-containing resin or elastomer includes: a step of preparing a filling material as a filler and a resin or elastomer comprising an incompatible blend; and a step of introducing the filling material-containing resin or elastomer into a material feed part provided at an end of a cylindrical melt-kneading part having a heater and provided with a screw, and then melt-kneading the filling material-containing resin or elastomer under conditions where the rotation speed of the screw is about 600 rpm to about 3,000 rpm and its shear rate is about 900 to about 4,500 sec−1, thereby forming a co-continuous structure comprising the incompatible blend.
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a synthetic apolipoprotein A-1 (Apo A-I) mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including a synthetic apolipoprotein A-I (Apo A-I) mimetic peptide, or combination of an Apo A-I synthetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of an endogenous Apo A-I related peptide. A composition including an apolipoprotein A-1 (Apo A-I) synthetic peptide in a form suitable for delivery into a blood vessel, the peptide including an amino acid backbone that has less amino acid residues relative to endogenous Apo A-I and a chimera of helix 1 and helix 9 of Apo A-I.
Abstract:
In general, in one aspect, the disclosures describes a method that includes receiving multiple ingress Internet Protocol packets, each of the multiple ingress Internet Protocol packets having an Internet Protocol header and a Transmission Control Protocol segment having a Transmission Control Protocol header and a Transmission Control Protocol payload, where the multiple packets belonging to a same Transmission Control Protocol/Internet Protocol flow. The method also includes preparing an Internet Protocol packet having a single Internet Protocol header and a single Transmission Control Protocol segment having a single Transmission Control Protocol header and a single payload formed by a combination of the Transmission Control Protocol segment payloads of the multiple Internet Protocol packets. The method further includes generating a signal that causes receive processing of the Internet Protocol packet.
Abstract:
In one embodiment, the present invention includes a translation lookaside buffer (TLB) having storage locations each including a priority indicator field to store a priority level associated with an agent that requested storage of the data in the TLB, and an identifier field to store an identifier of the agent, where the TLB is apportioned according to a plurality of priority levels. Other embodiments are described and claimed.
Abstract:
Nanoparticle-coated medical devices, nanoparticle-containing formulations and methods of using for treating a vascular disease are disclosed.
Abstract:
The present invention relates to the regional delivery of therapeutic agents for the treatment of vascular diseases wherein regional delivery refers to delivery of a therapeutically effective amount of the therapeutic agent to an area of the vessel that includes not only afflicted tissue but non-afflicted tissue at the periphery of the afflicted tissue as well.
Abstract:
In one embodiment, the present invention includes a method for maintaining data in a first level cache non-inclusively with data in a second level cache coupled to the first level cache. At the same time, at least a portion of directory information associated with the data in the first level cache may be maintained inclusively with a directory portion of the second level cache. Other embodiments are described and claimed.
Abstract:
A tape cartridge has a baseplate surrounded by a housing. Two hub pins are disposed within the housing substantially perpendicular to the baseplate. Each pin has top and bottom portions and a collared portion therebetween. The bottom portion of each pin is press-fitted into a mating aperture in the baseplate with the collared portion bearing against the baseplate. A large diameter tape hub is rotatably mounted on the top portion. The collared portions allow the hub pins to withstand heavy side loads without significantly deflecting from the perpendicular. Two large diameter tape hubs are rotatably mounted around the hub pins and improve the empty hub to full pack diameter ratios, and improve the resulting tangential drive force and tape tension profiles as the tape moves between the hubs. A back set of belt rollers includes a high-drag roller that engages the drive belt at a fixed wrap angle and produces a relatively constant drag. A front set of belt rollers includes a drive roller and has rollers mounted to form substantially equal geometries with rollers in the back set relative to the tape hubs. The constant wrap angle of a drive belt on the high-drag roller tends to outweigh varying drags from other rollers, causing less change in tape tension and tangential drive force as the tape is transferred from hub to hub in response to movement of the drive belt along a path in contact with the drive roller, the belt rollers, and the tape on the hubs.
Abstract:
FIG. 1 is a front perspective view of a backpack showing my new design. FIG. 2 is a front view of a backpack. FIG. 3 is a rear view of a backpack. FIG. 4 is a left side view of a backpack. FIG. 5 is a right side view of a backpack. FIG. 6 is a top view of a backpack; and, FIG. 7 is a bottom view of a backpack. Any shading and cross-hatching are not features of the design but are utilized to illustrate the surface contours of the backpack design in the drawings. The broken lines depict stitching lines and form part of the claimed design.